To maintain reliable signal transmission across a synapse, free synaptic neurotransmitters must be removed from the cleft in a timely manner. In the first visual synapse, this critical task is mainly undertaken by glutamate transporters (EAATs). Here we study the differential roles of the EAAT1, EAAT2 and EAAT5 subtypes in glutamate (GLU) uptake at the photoreceptor-to-depolarizing bipolar cell synapse in intact dark-adapted retina. Various doses of EAAT blockers and/or GLU were injected into the eye before the electroretinogram (ERG) was measured. Their effectiveness and potency in inhibiting the ERG b-wave were studied to determine their relative contributions to the GLU clearing activity at the synapse. The results showed that EAAT1 and EAAT2 plays different roles. Selectively blocking glial EAAT1 alone using UCPH101 inhibited the b-wave 2-24 h following injection, suggesting a dominating role of EAAT1 in the overall GLU clearing capacity in the synaptic cleft. Selectively blocking EAAT2 on photoreceptor terminals had no significant effect on the b-wave, but increased the potency of exogenous GLU in inhibiting the b-wave. These suggest that EAAT2 play a secondary yet significant role in the GLU reuptake activity at the rod and the cone output synapses. Additionally, we have verified our electrophysiological findings with double-label immunohistochemistry, and extend the literature on the spatial distribution of EAAT2 splice variants in the mouse retina.
Introduction
Glutamate is the neurotransmitter used by the first synapse in the retina (Copenhagen & Jahr, 1989; Massey, 1990; Massey & Redburn, 1987) . L-glutamate (GLU) is tonically released at a high rate in the dark by photoreceptors (Copenhagen & Jahr, 1989; Dowling & Ripps, 1973) and activates postsynaptic receptors on second-order neurons. Photoreceptors hyperpolarize in light (Baylor & Fuortes, 1970) , resulting in decreased vesicular GLU release, which modulates synaptic input to bipolar and horizontal cells (Attwell, 1990; Cervetto & MacNichol, 1972; Murakami et al., 1975) .
To ensure reliable signal transmission, synaptic GLU concentration must be regulated by quick removal of free GLU from the cleft. This is the classical role of excitatory amino acid transporters (EAATs), and is a two-step process. The transport turnover rate for GLU of the EAATs was found to be very slow (Wadiche et al., 1995b) , but the EAATs have high affinity to GLU (Diamond & Jahr, 1997) and are present at presynaptic terminals at high-density (Hasegawa et al., 2006) . Therefore, it is suggested that they clear free synaptic GLU in a way resembling a buffer (Tong & Jahr, 1994) instead of just a transporter. In the retina, glutamate not reabsorbed by the presynaptic EAATs is thought to be removed http://dx.doi.org/10.1016/j.visres.2014.07.020 0042-6989/Ó 2014 Elsevier Ltd. All rights reserved.
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and recycled through a secondary process, which involves transporting into the Muller cell via its membrane EAAT1 and conversion into glutamine before transporting back to the photoreceptors (Hertz et al., 1999) . To date, five subtypes of EAATs have been identified in the mammalian central nervous system (Danbolt, 2001; Shigeri et al., 2004) , namely EAAT1 to EAAT5. In retina, EAAT1 has been found on Müller cells in rat (Rauen et al., 1996) . EAAT2, also named GLT1, was found on rod and cone terminals in rat (Rauen & Kanner, 1994) and mouse (Haverkamp & Wassle, 2000) , but surprisingly not in mammalian Müller cells. GLT1 was further characterized as splice variants GLT1A, located in rod spherules, and GLT1B, in cone pedicles and some bipolar cells in rat (Reye et al., 2002) . EAAT3 was found to be present on the horizontal cells, amacrine cells and ganglion cells in the rat (Rauen et al., 1996; Schultz & Stell, 1996) . EAAT4 was found to be present on the Müller cells and astrocytes in rat retina (Ward et al., 2004) . EAAT5 has been shown to be present on presynaptic rod terminals in the mouse (Hasegawa et al., 2006; Wersinger et al., 2006) .
The objectives of the present study are to determine the differential roles of EAAT2, EAAT1 and EAAT5 in the signal inputs of depolarizing retinal bipolar cells (DBCs). The primary research hypothesis is that the above EAATs are responsible for the uptake/binding of free synaptic GLU in the outer plexiform layer and that pharmacologically inhibiting them would disrupt signal transmission between the photoreceptors and DBCs. Several specific and non-specific EAAT blockers are injected and their potencies in inhibiting the ERG b-wave (which originates from DBCs) were studied in intact dark-adapted mouse retina.
Our baseline data showed that the synthetic glutamate analogue (LAP4) was more potent than GLU in inhibiting the ERG bwave when injected intravitreally. There is a possibility that the difference in their potencies was because extracellular free GLU but not LAP4 was being removed by EAATs at the photoreceptorto-DBC synapses. Therefore, our research hypothesis is that the effect of extracellular GLU in saturating DBC signal transmission is influenced by the GLU clearing activities of EAATs. GLU was co-injected with EAAT blockers and the altered GLU potency in inhibiting the ERG b-wave was determined in intact dark-adapted retina.
The measured potencies of injected EAAT blockers and GLU under different conditions have shed light on the GLU clearing functions of various EAATs on the endogenous synaptic glutamate equilibrium. That was achieved by taking advantage of an infrared guided drug injection system and ERG recording techniques in total darkness. Such an approach is advantageous over others because it is more physiological as all in-vivo fluid flow and transporter systems in the eye are intact and functional. Also, the synaptically released glutamate would not be washed out by the perfused buffer as reported under in-vitro conditions (Winkler et al., 1999) , and any possible confounding global side-effects from permanently knocking out the EAATs Tanaka et al., 1997; Watase et al., 1998) could be avoided. In the second half of the study, we have confirmed our electrophysiological findings by double immunohistochemistry staining and extended the literature on the spatial distribution of EAAT2 splice variants in the mouse retina.
Materials and methods

Animals
One hundred and twenty-three Wildtype mice (C57BL/6) from Jackson Laboratories (Bar Harbor, ME) between 8 and 12 weeks old were used for experiments. Animals were treated in accordance with NIH guidelines and the Baylor College of Medicine IACUC welfare guidelines which complied with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
Intravitreal injection
Solutions containing glutamate (Cat. no. g1626, Sigma-Aldrich, St. Louis, MO), LAP4 (Cat. no. 0103, Tocris bioscience, Minneapolis, MN), dihydrokainic acid (Cat. no. 0111, Tocris bioscience) or TBOA (Cat. no. 1223, Tocris bioscience) were prepared by dissolving in sterile Balanced Salt Solution (Alcon, Fort Worth, TX). Solution containing UCPH (Cat. no. 3490, Tocris bioscience) was prepared by dissolving in Dimethyl sulfoxide (DMSO, Sigma-Aldrich). Unless otherwise stated, drug concentrations presented in the results were vitreal/retinal concentrations calculated assuming that the injected solution was diluted by 20 lL of vitreous (Gao et al., 2006; Saszik et al., 2002) .
Mice were first dark-adapted for a minimum of 2 h. Prior to intra-vitreal injection, mice were anaesthetized with weight-based intraperitoneal injection of solution containing ketamine (46 mg/ ml), xylazine (9.2 mg/ml), and acepromazine (0.77 mg/ml). After that, a single drop of 0.5% proparacaine hydrochloride, 1% tropicamide, and 2.5% phenylephrine was applied on the cornea for topical anesthesia and pupil mydriasis under dim red light. The injection procedure was performed under infrared illumination. First, a 32-gauge disposable needle was used to puncture the eye at the pars planar. Solutions containing the drug or the control were then injected in one eye using a NanoFil microinjection system (World Precision Instrument, FL) into the vitreous chamber through the puncture with a 34-gauge blunt needle visible behind the dilated pupil. The needle was allowed to stay for an additional 30 s in the eye after the injection to avoid any injected drug from escaping the eye when the needle was withdrawn. The volume of fluid injected was 1 lL for saline based drug, or 0.2 lL for DMSO based drug.
Electroretinogram
Immediately after intravitreal injection, mice were placed on a stereotaxic platform with their body temperature maintained at 39°C using a heating pad. Reference and ground electrodes were placed in the forehead and tail, respectively. A blunt platinum needle active electrode was placed in contact with the center of each cornea. Then a drop of methylcellulose gel (2.5%) was applied to the eye. The platform was then placed inside a Ganzfeld dome coated with highly reflective white paint (Munsell Paint, New Windsor, NY) and the mice were then allowed to remain in complete darkness for 3 min before recording.
All scotopic stimuli were generated using light emitting diodes as half millisecond square pulse of 505 nm peak wavelength. A scotopic ERG protocol comprised of progressively increasing stimuli strength was implemented to measure a-and b-waves in different zones as defined previously (Abd-El- Barr et al., 2009) to facilitate dissection of the rod and cone pathways. Saturating stimuli were generated with 1500 W xenon flash bulbs (Novatron, Dallas, TX) and attenuated with apertures and diffusers at the end of the scotopic protocol. All flashes were calibrated with a photometer (ILT1700 International Light, MA) and converted to the unit photoisomerizations/rod (R * /Rod), where 1 scot cd m 2 = 581 photoisomerization/rod/s (Lyubarsky et al., 2004; Saszik et al., 2002) . To study the time course for the effect of the injected drugs, the above protocol, which lasted 11 min, was implemented 4 times in the first hours following the injection. ERG signals were amplified using Grass P122 amplifiers (bandpass 0.1-1000 Hz; Grass Instruments, West Warwick, RI) and then acquired at a sampling rate of 10 kHz with a data acquisition board (USB-6216, National Instruments, TX). Signal averaging was employed to increase the signal-to-noise ratio of recorded ERG using custom codes written in Matlab (The MathWorks, Natick, MA). 25 Responses were averaged with an interval of 2 s between each flash at the lowest intensity. Fewer responses were averaged with a longer interval between flashes as the intensity of the flash increased. The scotopic b-wave was digitally filtered using the ''filtfilt'' function (low-pass filtered; F c = 60 Hz) in Matlab to remove oscillatory potentials before fitting. Dose-response curves showing the amplitude of b-wave against drug concentration were fitted using the DoseRep function of OriginPro v8.6 (OriginLab Corp., Northampton, MA) pharmacology toolbox. Statistical comparison between groups in this study was calculated using unpaired t-test, or one-way ANOVA with Tukey post-hoc analysis. Significant difference was defined as p < 0.05 unless otherwise stated. ERG data presented in this report are normalized to compensate for the effect from injecting the solvents (described in detail in Section 3.1 of the companion paper). For example, the normalized b-wave amplitude for the GLU injected group was calculated using the following equation:
normalized amplitude GLU ¼ amplitude GLU injected eye amplitude uninjected fellow eye
Â
Mean amplitude uninjected control eyes Mean amplitude saline injected eyes ð1Þ
Antibody characterization
The following antibodies were acquired from commercial suppliers for labeling specific cell types of the retina (Table 1) . Horizontal cells were immuno-labeled with a mouse monoclonal antibody against calbindin (de Melo et al., 2003) . Anti-GLT1A and Anti-GLT1B antisera were purchased from LifeSpan Bioscience (Seattle, WA) and Abcam plc (Cambridge, MA), respectively. The antiserum has been shown to label neurons in the CA1 region of the rat hippocampus (Rose et al., 2009 ). ON-cone bipolar cells and rod bipolar cells were immuno-stained with a mouse monoclonal or a rabbit polyclonal antibody against G-protein Goa (Haverkamp & Wassle, 2000) . Rod bipolar cells were immunolabeled with rabbit and mouse antibodies against PKCa (Zhang et al., 2005) . Rod photoreceptor spherules were labeled with anti-PSD95 antibody (Oh et al., 2007) . Fluorescein tagged peanut agglutinin (PNA) was used to stain cone pedicles (Blanks & Johnson, 1983 ).
Tissue preparation and immunohistochemistry
Mice were deeply anaesthetized when the eyes were enucleated, and then immediately euthanized by an overdose of anesthesia. The eyes were then dissected carefully to isolate whole retina, which was subsequently fixed in 4% paraformaldehyde (Electron Microscopy Science, Fort Washington, PA) in phosphate buffer (DPBS, Invitrogen, La Jolla, CA), pH 7.4, at room temperature for 45 min. IHC was performed using an indirect antibody method.
Retinae were cut into vertical sections 40 lm in thickness using a vibratome. Sections were dephosphorylated by incubating overnight with alkaline phosphatase as described previously (Reye et al., 2002) , and subsequently blocked with 10% donkey serum (Jackson Immunoresearch, West Grove, PA) in TBS (DPBS with 0.5% Triton X-100 (Sigma) and 0.1% sodium azide (Sigma), pH 7.2) at 4°C overnight to decrease nonspecific labeling.
The free-floating sections were incubated with primary antibodies at 4°C for 4 days in the presence of 3% donkey serum-TBS. Controls lacking primary antibodies were also processed. After several rinses, the sections were transferred and incubated overnight in 3% normal donkey serum-TBS solution containing donkey-hosted secondary antibodies conjugated with Cy5, Cy3 (1:200, Jackson Immunoresearch), or Alexa Fluor 488 (1:200, Molecular Probes, Eugene, OR) at 4°C. After rinsing several times, the sections were mounted with Vectashield medium (Vector Laboratories, Burlingame, CA) and coverslipped before being observed with a confocal laser scanning microscope (LSM 510; Zeiss, Thornwood, NY). Images were acquired using 40Â and 63Â oil-immersion objectives with Zeiss LSM software. Adobe Photoshop CS5 (Adobe Systems, San Jose, CA) was then used to crop images and uniformly apply identical brightness and contrast adjustments.
Results
Effects of exogenous glutamate on ERG in dark-adapted living mouse eyes
To establish the baseline potency of injected glutamate in inhibiting signal transmission, GLU was dissolved in saline and injected into the eyes of 30 mice. It was found that the exogenously introduced neurotransmitter inhibited the ERG b-wave (which originates from DBCs) shortly after its introduction. As shown in Fig. 1A , b-wave was inhibited the most at the 5 min post-injection time point and then recovered gradually during the 1 h window for all stimulus strengths. Using the baseline data established in The dose-response relationship between GLU concentration and b-wave amplitude was then determined using a titrating experimental approach, in which various concentrations of GLU were injected before ERG was measured. The data at the 5 min time point was chosen, when the inhibition was maximum, for the above purpose. Fig. 1B illustrates the residual b-wave amplitude against stimulus strength after injecting various concentrations of GLU. To facilitate dissection of the rod/cone pathways the stimulus strength is divided into four different zones (AbdEl- Barr et al., 2009) , which correspond to the operating ranges of different retinal neurons including rod, cone, DBC R , DBC C and AII amacrine cells (Fig. 1C ). For simplicity, zones I and II together may be regarded as scotopic zones, while zone III and IV may be respectively regarded as mesopic and photopic. Full inhibition of the b-wave was observed when measured with a zone III moderate stimulus but not with a weaker zone II or a stronger zone IV stimulus. The b-wave in zone III is most susceptible to the inhibition by exogenous GLU.
The amplitude of the b-wave is then normalized and plotted against the retinal concentration of GLU in Fig The fact that IC50 GLU s were higher than IC50 LAP4 s suggests that GLU is less potent than LAP4 on inhibiting the b-wave. There is no evidence that the GLU dose-dependent inhibition of b-wave was caused by a suppressed phototransduction. GLU inhibited the b-wave without systematically affecting the a-wave. As shown in Fig. 2D and E, increasing the concentration of GLU produced more variation but not a stronger or a systematic inhibition on the amplitude of a-wave. Because a-waves normally manifest as a PIII component truncated by a PII component (Granit, 1933) , it is likely that GLU increased the variation of the a-wave through suppressing the b-wave.
Effects of EAAT2 and EAAT1 blockers on ERG
To determine the role of EAAT2 and EAAT1 on the uptake of endogenous synaptic GLU, their blockers were injected into the mouse eye. Injected EAAT2 specific blocker dihydrokainic acid (130-fold selective for EAAT2 over EAAT1) partially inhibited the b-wave only when its concentration was high ( Fig. 3A and B) . The time course of inhibition differed depending on the stimulus strength (Fig. 3A) . For stimuli of 0.6 log R * /Rod or stronger, b-wave amplitudes decreased with time and were the lowest at the 50 min point. For stimuli of 0.1 log R * /rod or weaker, b-wave amplitudes were the lowest at the beginning and increased over the 50 min period measured. The inhibitory effects of dihydrokainic acid (DHK) on the b-wave were studied using a titrating experimental approach to establish the dose-response relationship. Twenty-six mice were injected with various concentrations of DHK and then ERG was used to monitor its effect on retinal functions. Data from the time point when inhibitions were at maximum were chosen for plotting the dose-response curves in Fig. 3C -E, at three stimulus strengths. DHK has IC50 values of 4.02, 4.30 and 4.67 log lM (10, 20 and 47 mM in linear scale) at stimulus strengths of 6.2, 1.8 and 0.1 log R * /rod, respectively. It partially inhibited amplitudes of the b-wave by 39%, 40% and 62% respectively at the above stimulus strengths. DHK had little effect on the amplitude of the a-wave and had a minor effect on increasing the latency of a-wave when it inhibited the b-wave, as illustrated in the representative raw ERG traces in Fig. 4A . Such effects were not so dose-dependent ( Fig. 4B and C) .
Six mice were injected with UCPH (a potent selective EAAT1 blocker) of 400 lM retinal concentration in one eye, while another six mice were injected with the solvent DMSO. It was found that amplitudes of the b-wave were partially inhibited by UCPH, and that the inhibition developed slowly in the first 24 h after injection and recovered significantly after another 9 days (Fig. 5A ). Inhibition was not observed during the first hour. Minor inhibition was detected 2 h after injection. At the 24th hour, injected eyes have mean b-wave inhibited by 41-27% relative to the fellow eye. UCPH produced 14-30% significantly stronger inhibitions than those of the DMSO. Inhibition was most prominent in zone II. There were no significant differences between UCPH and DMSO injected eyes in the amplitudes of the a-wave. Higher retinal concentration of UCPH was not tested because of the limited solubility of UCPH in DMSO, and the limited volume of DMSO that can be injected into the eye without affecting the b-wave.
Effects of co-injecting EAAT inhibitors and glutamate
To study the contribution of EAAT2 to the glutamate clearing activity in the photoreceptor-DBC synapse, glutamate (GLU) was co-injected with a threshold retinal concentration (200 lM or 2.3 log lM) of DHK. According to our earlier data ( Fig. 3B-E) , this concentration of DHK inhibited amplitudes of the b-wave by 10-23% at the 5 min time point depending on the stimulus strength.
The above paradigm was repeated in another group of mice using a threshold retinal concentration (0.5 lM or À0.3 log lM)
of TBOA, which is a non-specific EAAT blocker commonly used to study the effect of blocking EAAT5. In Section 3.3 of our companion paper, we have shown that TBOA inhibited the ERG b-wave in a dose-dependent manner similar to that of GLU or TBOA. The above threshold concentration of TBOA was found to inhibit the amplitude of the b-wave by 16-23% at various stimulus levels. The dose-response curves for GLU in the presence of DHK or TBOA (Fig. 6 ) were tested and modeled under the conditions described above. To isolate the effect of GLU, data were normalized to compensate for the minor inhibitory effects of DHK or TBOA with the following sample equation: 
As shown in Figs. 1B and 2A-C, intravitreally injected GLU produced the most inhibition of the b-wave measured with a zone III stimulus of log 1.8 R * /Rod, and lesser percentages of inhibition when measured with a weaker or a stronger stimuli. This inhibitory pattern was preserved when GLU was co-injected with either DHK or TBOA. The IC50 values for GLU were, however, quite different between mice injected with the two EAAT inhibitors. Under the strongest stimulus GLU had a lower value of 1.95 log lM (92 lM)
in the presence of DHK compared to the higher value of 4.25 log lM (18 mM) in the presence of TBOA ( Fig. 6A and B) .
The difference was 2.3 log units. Similar differences of 2.79 log units (1.24 versus 4.03 log lM) and 2.67 log units (1.58 versus 4.25 log lM) were found, respectively, using a moderate zone III stimulus ( Fig. 6C and D) and a weaker zone II stimulus ( (Field & Rieke, 2002; Nikonov et al., 2006) . M/S-cone range is extrapolated from the fact that many cones co-express both pigments (Applebury et al., 2000) . Ranges for DBC R , DBC C , and AIIAC are from light-evoked voltage-clamp results (Pang et al., 2004) . and F). These findings suggested that applied 200 lM DHK has a stronger effect than the applied 0.5 lM TBOA on increasing the potency of exogenous GLU, possibly through blocking the activities of membrane EAATs for removing free GLU.
By pooling the above data with the LAP4 data presented in Section 3.2 of the companion paper, Fig. 7 compares the doseresponse curves of GLU under 3 different conditions (injected alone, coinjected with DHK, or coinjected with TBOA) to the curve of LAP4. As illustrated, LAP4 has IC50 values 2.9-3.6 log units smaller than those of GLU. It is shown that GLU had its dose-response curves shifted largely toward the left when coinjected with DHK. The magnitudes of those left-shifts, when quantified using the IC50 values, was most prominent in zone IV and was equivalent to 86% of the difference in IC50 between GLU and LAP4. Equivalent shifts in IC50 were 72% and 74% in zone III and II, respectively. These suggest that EAAT2, selectively inhibited by the applied DHK, contributes to the removal of free synaptic glutamate in the photoreceptor-DBC synapses particularly in the cone-DBC synapses. These also indicate that the activity of EAAT2 was responsible for the difference between LAP4 and GLU in their potencies in inhibiting the b-wave.
In contrast, the presence of a threshold dose of TBOA did not consistently shift the GLU dose-response curve despite the fact that TBOA is a known non-specific EAAT blocker. In our companion paper, we have shown that TBOA effectively inhibited the b-wave (blocking synaptic glutamate clearing), then co-injecting GLU with them at their respective threshold concentrations should have shifted the respective measured GLU dose-response curves. Our finding that such left-shifting occurred only in the presence of DHK but not TBOA indicates that TBOA inhibited the b-wave through a different mechanism when applied at the selected low concentration, without significantly affecting the clearing activity for free synaptic GLU. Such mechanism was studied in our companion paper and was found to be mediated by the blockage of postsynaptic EAAT5-coupled chloride channels on the DBCs. We did not study the effect of coinjecting GLU with a high concentration TBOA. It is expected that the clearing activity for free synaptic GLU will be affected if TBOA is applied in high concentrations.
Immunohistochemistry
To anatomically identify and localize the hardware underlying the observed DHK-sensitive glutamate removal mechanism, a series of IHC experiments were performed using a combination of antibodies that label different neurons in the OPL. Fig. 8A shows that EAAT2a immuno-reactivity is present in multiple layers of the retina and is most prominent in the OPL. Fig. 8B shows that EAAT2a was not present on the presynaptic active zone of the cone pedicles. Fig. 8C shows that EAAT2a co-localized with PSD95 and suggested its presence on the rod terminal spherules. The absence of EAAT2a staining below the cone pedicles (Fig. 8D) indicated that DBC C dendrites post-synaptic to cones did not express EAAT2a. In contrast, the finding that EAAT2a co-localized with PKCa suggested its presence on DBC R dendrites (Fig. 8E-G) .
EAAT2b immuno-reactivity was also most prominent in the OPL (Fig. 9A) . Different from that of EAAT2a, EAAT2b was shown to be present on the active zone of cone pedicles (Fig. 9B and C) . It was found in the distal half of the OPL staining numerous spherical shapes, resembling rod spherules, but not in the other half of the OPL proximal to the cone pedicles (Fig. 9B) . EAAT2b appeared to be absent from DBC C s and DBC R s as no obvious colocalization with PKCa or Goa was observed ( Fig. 9C and D) .
Discussion
The present paper is the first to study the in-vivo glutamate clearing activity of EAATs in intact living mouse retina, by taking advantage of an infrared illuminated microinjection system, the non-invasive ERG technique and the newly available EAAT1 specific blocker UCPH101.
EAAT2 contributes substantially to the GLU clearing activity in photoreceptor output synapses
We showed that the ERG b-wave was suppressed immediately after injection of exogenous GLU, and recovered gradually afterward. The IC50 value for such GLU induced inhibition was found to be 3.58 log lM, which was 3.26 log units higher than that of LAP4 measured with a zone III stimulus (Fig. 7B) . Except for the above difference in potency, the patterns of GLU and LAP4 inhibition on the b-wave appeared qualitatively similar. This likely implies that GLU and LAP4 inhibited the b-wave through the same mechanism (saturating mGluR6) at the photoreceptor-DBC synapse, and that the lower potency of glutamate was possibly due to the selective affinity of EAATs for GLU but not LAP4. Because the ERG b-wave is generated by DBCs receiving synaptic input from the photoreceptors, the differences in their dose-response curves or IC50 values are likely indirect quantitative measures for the glutamate clearing activity at the photoreceptor synapse and along the diffusion pathway from the injected site to the synapse. The first line of evidence supporting this notion is provided by our IHC results, which confirmed the presence of EAAT2b on cone terminals, and the presence of EAAT2a, EAAT2b and EAAT5 (see companion paper for EAAT5 findings) on rod terminals.
Furthermore, coinjecting a low concentration (0.2 mM) of DHK (a EAAT2 blocker) with GLU increased the potency of GLU drastically for inhibiting the b-wave. As illustrated in Fig. 7 , the resultant GLU dose-response curve left-shifted to an extent more than half of the total difference between GLU and LAP4 for all three stimulus strengths when compared using the IC50 values. This second line of evidence strongly indicates that the glutamate clearing activity in both rod-DBC and cone-DBC synapses have been largely neutralized by DHK, and that the underlying EAAT subtype was the DHKsensitive EAAT2. Moreover, the left-shifting of IC50 GLU was most obvious in zone IV (Fig. 7A) where the left-shifted IC50 GLU became insignificantly different from the IC50 LAP4 . This correlates well with our IHC results which showed that cone presynaptic active zones express only EAAT2, while rod presynaptic active zones express both EAAT2 and EAAT5. The absence of a second EAAT type on cone terminals may have rendered its GLU clearing capacity more susceptible for DHK.
Selective inhibition of EAAT1 but not EAAT2 disrupts GLU equilibrium in photoreceptor synapses and reduces the b-wave
Our data showed that temporarily blocking EAAT1 using injected UCPH partially inhibited the b-wave. Compared to other EAAT blockers, the effect of UCPH was slower.
It is possible that the slow time course of UCPH inhibition was a result of slower migration of UCPH molecule form the injection site to the Muller cells. Unlike the other tested drugs, UCPH is soluble in DMSO, poorly soluble in water, and has a heavier molecular weight (UCPH: 422, DHK: 215, TBOA: 239). Partial reductions in the b-wave amplitudes, similar to those produced by UCPH, have also been reported previously when EAAT1 was being suppressed permanently through genetic knockout (Harada et al., 1998) or by antisense oligonucleotide administration (Barnett & Pow, 2000) . Inhibition on the ERG b-wave produced by injecting antisense oligonucleotide was also slow. In mouse retina, EAAT1 is not present on photoreceptor terminals but on Müller cells, which wrap around the photoreceptor-DBC synapse. It may function as a GLU reuptake mechanism in the synapse, and its inhibition may have led to the accumulation of endogenous GLU in the synapse, or a perturbed glutamate-glutamine recycling between Müller cells and photoreceptors (Pow & Robinson, 1994) , and subsequently an inhibition of the b-wave. An alternative explanation for the slow action of UCPH is that accumulation of synaptic GLU was slow, when the other EAATs at the synapse remained functional.
In contrast, blocking EAAT2 alone did not significantly inhibit the b-wave. Our data showed that 0.2 mM DHK effectively shifted the GLU dose-response curve when co-injected, but has little effect on the b-wave when injected alone. This suggests that blocking EAAT2 alone does not cause accumulation of endogenous GLU in the photoreceptor-DBC synapse in the presence of functional EAAT1. The fact that selectively blocking EAAT1 produced stronger inhibition on the b-wave than selectively blocking EAAT2 is intriguing, because EAAT2 has a similar affinity for GLU (Arriza et al., 1994) , a faster turnover rate (Bergles & Jahr, 1998; Wadiche & Kavanaugh, 1998) compared to EAAT1, and is located closer to the GLU release site. One possible explanation is that the total number of EAAT1 transporters may be much higher than that of EAAT2 at the synapse, so that its blockage resulted in a higher impact on the overall GLU removing capacity and the accumulation of GLU.
A higher concentration of DHK (15 mM) inhibited the ERG bwave though when injected alone. At higher stimulus levels within the operational range of cones, inhibition was weaker at the beginning but developed gradually with time during the 1 h period tested (Fig. 3A) . A different time course was observed at lower DHK + GLU, 5min
[GLU] (log µM)
TBOA + GLU, 5min
Mean stimulus levels at which only rods were functional. Since we have shown in the co-injection experiment that 0.2 mM DHK was very effective in inhibiting the GLU clearing activity of EAAT2, this direct inhibition of the b-wave by a higher concentration DHK probably involved a second mechanism. Given that DHK is 130-fold more selective for EAAT2 (K i = 23 lM) over EAAT1 (K i P 3 mM), we postulate that DHK non-specific blocking of EAAT1 was responsible. In our ERG results, the time course for inhibition of the b-wave was much faster in the rod operative range. This may imply that rod-DBC synapses, compared to cone-DBC synapses, are more dependent on the EAAT1 on Müller cells to maintain its GLU equilibrium. Alternatively, it is also possible that the fast onset inhibition of the b-wave following injection resulted from a direct inhibition of post-synaptic EAAT2a on DBC R by DHK. This blocked the EAAT gated chloride channel in the dark, making the membrane resting potential less hyperpolarized and subsequently reduced the bwave generated by the DBC R during the light-elicited depolarization. It has been reported that EAAT2 mediates a small but measurable chloride conductance (Wadiche et al., 1995a ), compared to that of EAAT5 (Arriza et al., 1997) .
EAAT5 inhibited the b-wave without significantly affecting the glutamate clearing capacity
Our data has shown that the presence of co-injected TBOA did not consistently shift the GLU dose-response curves. TBOA is a known inhibitor for EAAT 1-5, and should have left-shifted the GLU dose-response curve if it had functioned like DHK and blocked the presynaptic EAATs in the synapse. The best explanation for this result is that the applied TBOA concentration (0.5 lM) was too low to effectively neutralize the GLU clearing capacity of EAATs in the photoreceptor-DBC synapse. Given the fact that the same concentration of TBOA inhibited the b-wave by 16-23% and 45-48% in wildtype and bhlhb4 À/À mice, respectively, when injected alone (see Section 3.3 of the companion paper), it is indicated that the mechanism through which low concentration TBOA inhibited the b-wave did not involve blockage of presynaptic EAATs and saturation of synaptic GLU. EAAT5 is known for its dual functions of GLU transporter and GLU-gated chloride channels (Arriza et al., 1997; Sonders & Amara, 1996) . We presented evidences in our companion paper that the above inhibition was mediated through the EAAT5-coupled chloride channel on cone depolarizing bipolar cell dendrites.
Rod-DBCc synapse is more susceptible to inhibition by exogenous GLU
Our results have shown that the b-wave measured with zone III stimuli was inhibited most strongly by exogenous GLU (Fig. 1B and  C) . It has been previously characterized that the Rod-DBCc pathway is particularly active at that intensity (Abd-El- Barr et al., 2009) . This indicates that the Rod-DBC C synapse is more susceptible to influence by exogenous GLU. One possible explanation for this could be that the Rod-DBC C synapse has a weaker diffusion barrier for exogenous molecules compared to other photoreceptor-to-DBC synapses.
Conclusion
The present study has provided electrophysiological, pharmacological and immunohistological evidences for the functions of EAAT1 on Müller cells, EAAT2b on cone terminals, and the functions of EAAT2a, EAAT2b and EAAT5 on rod terminals in intact dark-adapted retinae of living mice. Selective inhibition of EAAT1 using a newly available blocker (UCPH101) has led to reductions in the b-wave suggesting that the EAAT1 on Müller cells is neces- LAP4 has an IC50 value 2.9 log units lower than that of GLU. The presence of DHK shifts the GLU curve to the left and significantly (p < 0.01) reduces the IC50 value from 4.47 to 1.96 log lM (86% of the total difference between IC50 GLU and IC50 LAP4 ).
There was no difference between IC50 LAP4 and IC50 GLU+DHK (p > 0.05). Coinjecting with TBOA did not significantly shift the IC50 value for GLU (p > 0.05). (B) Doseresponse curves measured with a moderate zone III stimulus. LAP4 has an IC50 value 3.2 log units lower than that of GLU. The presence of DHK shifts the GLU curve to the left and significantly (p < 0.01) reduces its IC50 from 3.58 to 1.24 log lM (72% of the difference). TBOA has no significant effect on IC50 GLU . (C) Dose-response curves measured with a scotopic zone II stimulus. LAP4 has an IC50 value 3.6 log units lower than that of GLU. The presence of DHK shifts the GLU curve to the left and significantly (p < 0.01) reduces its IC50 from 4.21 to 1.58 log lM (74% of the difference), while TBOA has little effect on IC50 GLU . sary to maintain proper photoreceptor-to-DBC signal transmission by acting as the major GLU reuptake mechanism, which is characterized by a slower turnover rate but an overall higher clearing capacity. The b-wave was inhibited by selective inhibition of EAAT1, but not selective inhibition of EAAT2, suggesting that EAAT1 plays a dominating role in GLU reuptake in the synaptic cleft. The clearing activity for exogenous GLU at the cone and rod terminals can be neutralized largely by DHK, indicating that it is mediated by EAAT2 at the photoreceptor-DBC synapse. The close proximity of EAAT2 to the GLU release site and its higher turnover rate imply a significant role of EAAT2 in the timely reabsorption of GLU to the photoreceptor terminal. Low concentration of non-specific EAAT blocker (TBOA) inhibited the b-wave without affecting the GLU clearing activity, suggesting the presence of a TBOA-sensitive postsynaptic receptor in the synapse. 
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